Sunday, November 26, 2006

Corcept Therapeutics Completes Enrollment in Third Phase 3 Study ...



PR Newswire (press release), NY - Nov 13, 2006... 09, treatment with antipsychotic medications or electroconvulsive therapy is not be allowed at any time during this study. About Psychotic Major Depression PMD ...
Source: www.prnewswire.com

Targacept Announces Positive Results of Phase II Clinical Trial in ...
Earthtimes.org - Nov 9, 2006... study indicates the potential for a new treatment option for the millions of patients suffering from major depression for whom current treatment modalities are ...
Source: www.earthtimes.org

Targacept reports mixed depression drug data
Pharmaceutical Business Review - Nov 10, 2006A phase II trial of mecamylamine hydrochloride as an augmentation treatment for major depression has delivered mixed results, its manufacturer Targacept has ...
Source: www.pharmaceutical-business-review.com

Speaker Silver needs to change his mind
Troy Record, NY - Nov 24, 2006... an ailment rooted in a physical imperfection in the brain, treatment is too ... and at-risk children - including health issues such as major depression and panic ...
Source: www.troyrecord.com

Depression study shows treatment difficulties
Orlando Sentinel, FL - Nov 6, 2006... scientists tracked 3,671 adults who had been diagnosed with major depression. ... life circumstances or other medical conditions that interfered with treatment. ...
Source: blogs.orlandosentinel.com

Click here for more information about elderly depression elderly depression